Lasarus
3 known investors
Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.
Investors · 3
Competitors · 1
by search overlapCompanies competing with Lasarus for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase ISTTR | 2021 | $256K |
| National Science Foundation | Phase ISTTR | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Lasarus do?
- Lasarrus is developing WearME, a multimodal wearable system that continuously monitors six vital signs to detect COPD exacerbations early, giving clinicians up to 48 hours of advance warning. The remote patient monitoring system is aimed at healthcare providers and clinical staff managing patients with chronic obstructive pulmonary disease.
- Who are Lasarus's investors?
- Lasarus's investors include Atlanta Technology Angels, Maryland TEDCO, TEDCO.